PetIQ, Inc. (PETQ)

Market Cap	475.18M
Revenue (ttm)	1.10B
Net Income (ttm)	2.13M
Shares Out	29.19M
EPS (ttm)	0.07
PE Ratio	232.57
Forward PE	12.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	147,964
Open	15.95
Previous Close	16.03
Day's Range	15.95 - 16.43
52-Week Range	11.26 - 22.98
Beta	1.68
Analysts	Strong Buy
Price Target	29.00 (+78.13%)
Earnings Date	May 7, 2024

About PETQ

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jul 21, 2017
• Employees: 1,121
• Stock Exchange: NASDAQ
• Ticker Symbol: PETQ

Analyst Forecast

According to 4 analysts, the average rating for PETQ stock is "Strong Buy." The 12-month stock price forecast is $29.0, which is an increase of 78.13% from the latest price.

Price Target

$29.0

(78.13% upside)

Analyst Consensus: Strong Buy